ARCHIVES

Xeloda-Eloxatin Study Updated; Phase III Trial Interim Analysis

This article is from The Cancer Letter archive.

Vol. 25 No. 12 | December 27, 2002

Download PDF Visit The Full Archive

Related Articles

NCI Programs: Institute Partners With Two Groups On Psychosocial Issues

May 16, 1997

Female Smokers Face Double Risk For Lung Cancer

July 28, 2006

Excerpts From A Confidential Report Detailing the I-ELCAP Study’s Design Flaws and Lack of Consent

April 29, 2011

No Cancer Letter For Next Two Weeks

August 30, 1991

Trial Tests Selenium, Vitamin E In Prostate Cancer Prevention.

July 27, 2001

ASCO: NCI Authorities Still Important

June 11, 2010